TONIX PHARMACEUTICALS HLDG C's ticker is and the CUSIP is 890260706. A total of 25 filers reported holding TONIX PHARMACEUTICALS HLDG C in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $7,916,000 | -27.7% | 34,392,362 | +12.3% | 0.00% | – |
| Q4 2021 | $10,956,000 | -33.3% | 30,631,558 | +12.1% | 0.00% | – |
| Q3 2021 | $16,422,000 | -44.2% | 27,321,653 | +3.1% | 0.00% | -100.0% |
| Q2 2021 | $29,416,000 | +202.3% | 26,501,101 | +248.6% | 0.00% | – |
| Q1 2021 | $9,731,000 | +880.0% | 7,602,535 | +416.6% | 0.00% | – |
| Q4 2020 | $993,000 | -19.7% | 1,471,654 | 0.0% | 0.00% | – |
| Q3 2020 | $1,236,000 | – | 1,471,654 | +2776605.7% | 0.00% | – |
| Q2 2020 | $0 | – | 53 | 0.0% | 0.00% | – |
| Q1 2020 | $0 | – | 53 | +1.9% | 0.00% | – |
| Q4 2019 | $0 | – | 52 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|